Related Experiment Videos
Paraneoplastic disorders of neuro-ophthalmologic interest
1Neuro-ophthalmology (4F-2), Marshfield Clinic, WI 54449, USA.
Abstract:
Certain paraneoplastic disorders associated with degeneration of the retina, optic nerve, brainstem, and cerebellum may cause visual loss, impairment of ocular motility, or nystagmus and other saccadic intrusions and oscillations. Most of these remote effects of cancer are probably autoimmune conditions. Many affected patients have circulating antineuronal antibodies that serve to identify the autoimmune nature of their clinical presentation and allow the treating physician to target the evaluation to certain organs likely to be harboring an occult malignancy associated with that particular remote effect. Because patients with paraneoplastic disorders affecting vision and eye movement frequently develop symptoms before their underlying cancer is diagnosed, they will typically seek the assistance of an ophthalmologist first. Recognition that their symptoms or findings reflect a paraneoplastic syndrome may allow the tumor responsible for its presentation to be diagnosed at an earlier stage, which might positively influence the patient's overall prognosis.
Insights
Certain paraneoplastic disorders can cause vision and eye movement issues, often indicating an underlying autoimmune cancer. Early recognition by ophthalmologists aids in timely cancer diagnosis and potentially improves patient prognosis.
Area of Science:
- Neuro-Ophthalmology
- Oncology
- Autoimmunology
Background:
- Paraneoplastic disorders can manifest as neurological symptoms affecting vision and eye movements.
- These remote effects of cancer are frequently autoimmune in nature.
- Ophthalmologists are often the first specialists to evaluate patients with these symptoms.
Purpose of the Study:
- To highlight the connection between paraneoplastic neurological disorders and underlying malignancies.
- To emphasize the role of antineuronal antibodies in diagnosing these conditions.
- To underscore the importance of early recognition for improved cancer detection and patient outcomes.
Main Methods:
- Review of clinical presentations of paraneoplastic disorders affecting the visual system.
- Discussion of the diagnostic utility of antineuronal antibodies.
- Analysis of the temporal relationship between paraneoplastic symptoms and cancer diagnosis.
Main Results:
- Paraneoplastic syndromes can precede the diagnosis of the primary cancer.
- Circulating antineuronal antibodies are key biomarkers for identifying autoimmune processes.
- Prompt ophthalmological evaluation can lead to earlier cancer detection.
Conclusions:
- Recognition of paraneoplastic syndromes by ophthalmologists is crucial for early cancer diagnosis.
- Identifying antineuronal antibodies aids in pinpointing occult malignancies.
- Earlier diagnosis of the underlying cancer through paraneoplastic symptom recognition can positively impact prognosis.